OptimizeRx Corp

 

May 22, 2014

 

THE UNITED STATES SECURITIES

AND EXCHANGE COMMISSION

Attn: Mark P. Shuman

Division of Corporation Finance

Mail Stop 7010

100 F. Street NE

Washington, D.C. 20549-7010

 

Re:OptimizeRx Corp

Registration Statement on Form S-1

File No. 333-195210

 

Dear Mr. Shuman:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, OptimizeRx Corp (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 to 4:00 PM Eastern Standard Time on May 27, 2014, or as soon thereafter as is practicable.

 

The Company acknowledges the following:

 

 

Thank you for your assistance. Please call with any questions.

 

OptimizeRx Corp

 

By:

/s/ David Harrell

David Harrell

Chief Executive Officer

 

 

400 Water Street Suite 200

Rochester, MI, 48307- Phone: 248 651-6568